Skip to main content

Table 1 Inhibitors used in this study.

From: Evaluation of signal transduction pathways after transient cutaneous adenoviral gene delivery

Bay11-7085 nuclear factor κB (NFkB)
PD 98,059 extracellular regulated kinase 2 (Erk2); mitogen-activated protein kinase kinase (MAPKK)
SB203580 p38 mitogen-activated protein kinase (p38 MAPK)
LY294,002 phosphoinositid-3-kinase (PI3K)
Tyrphostin AG 490 januskinase/signal transductor and aktivator of transcription (JAK/STAT)
SP600125 c-Jun N-terminal kinase (JNK)